Albert Calmette

Albert Calmette (July 12, 1863 – October 29, 1933) was a French physician, bacteriologist, and immunologist who, together with Camille Guérin, developed the Bacillus Calmette-Guérin (BCG) vaccine for tuberculosis. Calmette's work in developing the BCG vaccine marked a significant advancement in the fight against tuberculosis, a disease that was a leading cause of death in the early 20th century.

Early Life and Education

Albert Calmette was born in Nice, France. He began his medical studies at the Naval Medical School in Bordeaux, where he developed an interest in microbiology and infectious diseases. After completing his education, Calmette served in the French Navy, where he was exposed to various tropical diseases, further piquing his interest in infectious disease research.

Career

In 1891, Calmette joined the Pasteur Institute, where he worked under the guidance of Louis Pasteur and Emile Roux. His early work at the institute involved research on venomous snakes and the development of antivenoms. This work led to the establishment of antivenom institutes in countries around the world.

Calmette's focus shifted to tuberculosis in 1901 when he was appointed the director of the Pasteur Institute in Lille, France. It was here that he began his collaboration with Camille Guérin, a veterinarian and bacteriologist. Together, they embarked on a quest to develop a vaccine against tuberculosis. After 13 years of research, they succeeded in creating the BCG vaccine in 1921. The vaccine was made from a weakened strain of Mycobacterium bovis, a bacterium closely related to the human tuberculosis bacterium, Mycobacterium tuberculosis.

Legacy

Albert Calmette's contribution to medicine and public health is monumental. The BCG vaccine has been used worldwide and is one of the oldest vaccines still in use today. It has significantly reduced the incidence of tuberculosis in many countries. Calmette's work laid the foundation for modern immunology and vaccine development.

Calmette also made significant contributions to the treatment and prevention of other infectious diseases, including leprosy and snake bites. His work in establishing antivenom institutes has saved countless lives.

Death and Honors

Albert Calmette died on October 29, 1933, in Paris, France. His legacy lives on through the continued use of the BCG vaccine and his contributions to the fields of immunology and bacteriology. He was honored with numerous awards and recognitions during his lifetime, and his name is commemorated in various institutions and awards dedicated to public health and scientific research.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian